Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
16:19
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

52nd ERA-EDTA Congress

 

28-31 May 2015 London
FAQs
   
Discussion forum - 52nd ERA-EDTA Congress
    Topic - C) Renal development and cystic diseases.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
PERCUTANEOUS SCLEROTHERAPY VERSUS LAPAROSCOPIC CYST ABLATION FOR GIANT, SYMPTOMATIC RENAL CYSTS  Liliana Tuta 1      5/18/2015 9:27:00 PM  
URINARY PROTEOMIC BIOMARKERS, A POWERFUL TOOL FOR PROGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PROGRESSION  Martin Pejchinovski 1      5/18/2015 9:14:00 PM  
PKD1 AND PKD2 MUTATION ANALYSIS IN 90 UNRELATED ITALIAN PEDIGREES WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): SANGER SEQUENCING VS NEXT GENERATION SEQUENCING (NGS).  Sterpeta Diella 1      5/18/2015 3:59:00 PM  
ADPKD IS A BARRIER TO EMPLOYMENT IN EUROPE  Andrew Makin 1      5/18/2015 12:54:00 PM  
ADPKD DIAGNOSIS IN EUROPE: PATIENT REPORTS OF SYMPTOMS AT RECOGNITION AND POST DIAGNOSIS SUPPORT  Andrew Makin 1      5/18/2015 12:48:00 PM  
Autosomal dominant polycystic kidney disease does not in itself appear to cause thrombocytopenia  Stella Setyapranata 1      5/17/2015 7:44:00 AM  
BODY COMPOSITION MEASUREMENTS USING BIOIMPEDANCE ANALYSIS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS TREATED WITH TOLVAPTAN.  MINORU MAKITA 1      5/16/2015 8:43:00 AM  
HEMATURIA AND LOW BACK PAIN - THINK OF NUTCRACKER SYNDROME  Claudio Musetti 1      5/15/2015 6:12:00 PM  
SERUM VITAMIN D LEVELS AND EXPRESSION OF VITAMIN D RECEPTOR (VDR) IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE(ADPKD).  Larissa Collis Vendramini 1      5/13/2015 6:19:00 PM  
Does polyuria associated with vasopressin V2 receptor antagonismresult in an increased ureter diameter in ADPKD patients?  Niek Casteleijn 1      5/13/2015 11:09:00 AM  
THE BURDEN OF TOLVAPTAN TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)  SATORU MUTO 1      5/10/2015 10:02:00 AM  
LONG-TERM RENAL OUTCOME OF A LARGE COHORT OF PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX  Djalila Mekahli 1      5/8/2015 7:42:00 PM  
THE CARDIOVASCULAR EVENTS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS IN TAIWAN  Ping-Hsun Wu 1      4/17/2015 5:54:00 PM  
       




Most viewed poster for this congress
Poster: 625
Visits: 3858
Title: IS 4 CITRATE AN EFFECTIVE TOOL AS A CATHETER LOCKING SOLUTION?
Authors: Joao Fazendeiro Matos ,
Centre: Fresenius Medical Care | NephroCare Portugal

Poster most viewed in this topic
Poster: 58
Visits: 238
Title: THE BURDEN OF TOLVAPTAN TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
Authors: SATORU MUTO ,
Centre: Teikyo University


 






PosterSessionOnline
Logo Draft
 
Logo Cert